Abhishek Goel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abhishek Goel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aachal Gupta
Amity Reg High Sch, Woodbridge, CT USA
1 shared publication - Bhupinder Singh
Government Medical College, Amritsar, India
1 shared publication - Durgesh Kumar Agrawal
Nazareth Hosp, Dept Med, Philadelphia, PA USA
1 shared publication - Fnu Anamika
University College of Medical Sciences, New Delhi, India
1 shared publication - Kanishk Aggarwal
Dayanand Medical College and Hospital
1 shared publication - Rohit Jain
Penn State Milton S. Hershey Medical Center
1 shared publication
Latest Publications
- Open Access
- 30 October 2024
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (4) , 414-427
Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
Nonalcoholic fatty liver disease (NAFLD) has been shown to be linked to inflammatory bowel disease (IBD) due to established risk factors such as obesity, age, and type 2 diabetes in numerous studies. However, alternative research suggests that factors related to IBD, such as disease activity, duration, and drug-induced toxicity, can contribute to NAFLD. Recent research findings suggest IBD relapses are correlated with dysbiosis, mucosal damage, and an increase in cytokines. In contrast, remission periods are characterized by reduced metabolic risk factors. There is a dichotomy evident in the associations between NAFLD and IBD during relapses and remissions. This warrants a nuanced understanding of the diverse influences on disease manifestation and progression. It is possible to provide a holistic approach to care for patients with IBD by emphasizing the interdependence between metabolic and inflammatory disorders.
- 30 October 2024
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (4) , 414-427
Open AccessComplex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
Nonalcoholic fatty liver disease (NAFLD) has been shown to be linked to inflammatory bowel disease (IBD) due to established risk factors such as obesity, age, and type 2 diabetes in numerous studies. However, alternative research suggests that factors related to IBD, such as disease activity, duration, and drug-induced toxicity, can contribute to NAFLD. Recent research findings suggest IBD relapses are correlated with dysbiosis, mucosal damage, and an increase in cytokines. In contrast, remission periods are characterized by reduced metabolic risk factors. There is a dichotomy evident in the associations between NAFLD and IBD during relapses and remissions. This warrants a nuanced understanding of the diverse influences on disease manifestation and progression. It is possible to provide a holistic approach to care for patients with IBD by emphasizing the interdependence between metabolic and inflammatory disorders.